Literature DB >> 16541400

Bilirubin degradation by uncoupled cytochrome P450. Comparison with a chemical oxidation system and characterization of the products by high-performance liquid chromatography/electrospray ionization mass spectrometry.

Francesco De Matteis1, Gwyn A Lord, Chang Kee Lim, Nicoletta Pons.   

Abstract

Bilirubin is a protective antioxidant; however, when its conjugation and excretion are impaired, as in neonatal and hereditary jaundice, bilirubin accumulates and may cause severe neurotoxicity. Degradation of bilirubin takes place (a) on interaction with oxidative free radicals and (b) when cytochrome P450 (CYP) enzymes are uncoupled by polyhalogenated substrate analogues. The products of pathways (a) and (b) above have now been characterized by high-performance liquid chromatography/electrospray ionization mass spectrometry (HPLC/ESI-MS) and the mechanisms of fragmentation in part clarified. Oxidation of bilirubin by uncoupled CYP1A5 and by a Fe-EDTA/H2O2 system produced both biliverdin and an identical profile of dipyrrolic fragments, as detected by positive ESI-MS. A similar profile of oxidation products was found from mesobilirubin, all showing the expected increase in mass, thus providing direct evidence for fragmentation at the central methene bridge of the tetrapyrroles. Two degradation products, also detected by negative ESI-MS, were characterized as dipyrroles retaining the central bridge carbon, with one or two oxygen atom(s) bound (probably as the aldehyde and hydroperoxide derivatives). Ions compatible with propentdyopents and bilifuscins were also detected, but here the assignment was less certain. It is concluded that the first step in the oxidation of bilirubin may be hydrogen abstraction at the central methene bridge. This is followed either by loss of another hydrogen to give biliverdin, or by oxygen binding and fragmentation. Fe-EDTA/H2O2 and uncoupled CYP(Fe=O) may both initiate the reaction, the latter in an attempt to reduce the ferryl oxygen to water. These studies shed light on the CYP uncoupling mechanism and are of potential significance for the therapy of severe jaundice. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541400     DOI: 10.1002/rcm.2431

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  8 in total

1.  Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.

Authors:  W L Wurster; G J Pyne-Geithman; I R Peat; J F Clark
Journal:  Acta Neurochir Suppl       Date:  2008

2.  Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.

Authors:  Ghassan J Maghzal; Meng-Choo Leck; Emma Collinson; Cheng Li; Roland Stocker
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

3.  Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.

Authors:  Silvia Gazzin; Nathalie Strazielle; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

4.  Heme Degradation by Heme Oxygenase Protects Mitochondria but Induces ER Stress via Formed Bilirubin.

Authors:  Andrea Müllebner; Rudolf Moldzio; Heinz Redl; Andrey V Kozlov; J Catharina Duvigneau
Journal:  Biomolecules       Date:  2015-04-30

5.  Identification of a biliverdin geometric isomer by means of HPLC/ESI-MS and NMR spectroscopy. Differentiation of the isomers by using fragmentation "in-source".

Authors:  Rafał Frański; Błażej Gierczyk; Łukasz Popenda; Małgorzata Kasperkowiak; Tomasz Pędzinski
Journal:  Monatsh Chem       Date:  2018-02-13       Impact factor: 1.451

6.  Bright ligand-activatable fluorescent protein for high-quality multicolor live-cell super-resolution microscopy.

Authors:  Jiwoong Kwon; Jong-Seok Park; Minsu Kang; Soobin Choi; Jumi Park; Gyeong Tae Kim; Changwook Lee; Sangwon Cha; Hyun-Woo Rhee; Sang-Hee Shim
Journal:  Nat Commun       Date:  2020-01-14       Impact factor: 14.919

7.  A New Product of Bilirubin Degradation by H2O2 and Its Formation in Activated Neutrophils and in an Inflammatory Mouse Model.

Authors:  Fei-Fei Yu; Yao Yuan; Yan Ao; Li Hua; Wu Wang; Yiyi Cao; Jing Xi; Yang Luan; Shangwei Hou; Xin-Yu Zhang
Journal:  Biomolecules       Date:  2022-09-04

8.  The Extent of Intracellular Accumulation of Bilirubin Determines Its Anti- or Pro-Oxidant Effect.

Authors:  Annalisa Bianco; Aleš Dvořák; Nikola Capková; Camille Gironde; Claudio Tiribelli; Christophe Furger; Libor Vitek; Cristina Bellarosa
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.